Overview

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether NXL104 plus ceftazidime is effective in the treatment of complicated urinary tract infections as compared to a comparator group.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Pfizer
Treatments:
Avibactam
Ceftazidime
Cilastatin
Imipenem